[1] ILORI EA, FURUSE Y, IPADEOLA OB, et al.Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1-May 6, 2018[J]. Emerg Infect Dis, 2019, 25(6):1066-1074. [2] FRAME JD, BALDWIN JM JR, GOCKE DJ, et al.Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings[J]. AM J Trop Med Hyg, 1970, 19(4):677. [3] AJAYI NA, UKWAJA KN, IFEBUNANDU NA, et al.Lassa fever-full recovery without ribavarin treatment: a case report[J]. Afr Health Sci, 2014, 14(4):1074-1077. [4] MONATH TP, NEWHOUSE VF, KEMP GE, et al.Lassa Virus Isolation from Mastomys natalensis Rodents during an Epidemic in Sierra Leone[J]. Science, 1974, 185(4147):263-265. [5] LECOMPTE E, FICHET-CALVET E, DAFFIS S, et al.Mastomys natalensis and Lassa Fever, West Africa[J]. Emerg Infect Dis, 2006, 12(12):1971-1974. [6] BATY RS, ALBRAKATI A, FARAG MA, et al.Infection pattern, case fatality rate and spread of Lassa virus in Nigeria[J]. BMC Infect Dis, 2021, 2021(21):1-9. [7] JETOH RW, MALIK S, SHOBAYO B, et al.Lassa fever cases in Liberia epidemiological characteristics: a retrospective analysis of surveillance data, 2019-2020[J]. Int J Infect Dis, 2022, 122: 767-774. [8] BALOGUN OO, AKANDE OW, HAMER DH.Lassa Fever: An Evolving Emergency in West Africa[J]. AM J Trop Med HY, 2021,104(2):466-473. [9] SAFRONETZ D, MIRE C, ROSENKE K, et al.A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses[J]. PLoS Negl Trop Dis, 2015, 9(4): e0003736. [10] OKOROIWU HU, LÓPEZ-MUÑOZ F, POVEDANO-MONTERO FJ. Bibliometric analysis of global Lassa fever research (1970-2017): A 47-Year study[J]. BMC Infect Dis, 2018, 18(1):639. [11] MERSON L, BOURNER J, JALLOH S, et al.Clinical characterization of Lassa fever: A systematic review of clinical reports and research to inform clinical trial design[J]. PLoS Negl Trop Dis, 2021, 15(9): e0009788. [12] SOGOBA N, FELDMANN H, SAFRONETZ D.Lassa Fever in West Africa: Evidence for an Expanded Region of Endemicity[J]. Zoonoses Public HLTH, 2012, 59(2):43-47. [13] ETHEL NC, PETER EC, BASIL CE.Clinical Presentations of Lassa Fever in Non-Endemic Parts of the World: A Systematic Review[J]. Int J Clin Med, 2022, 13(9):415-427. [14] THAIRU Y, EGENTI N.Understanding Lassa fever and diversification of rodent vector in the tropics[J]. Int J Curr Med Res, 2015, 4: 372-378. [15] 中华预防医学会感染性疾病防控分会,中华医学会感染病学分会. 肾综合征出血热防治专家共识[J]. 中国实用内科杂志, 2021, 41(10): 845-854. [16] SIDDALL E, KHATRI M, RADHAKRISHNAN J.Capillary leak syndrome: etiologies, pathophysiology, and management[J]. Kidney Int, 2017, 92(1): 37-46. [17] 赵新华, 高燕军, 赵亮, 等. 急性炎性脱髓鞘脑病52例临床与影像学分析[J]. 河北医学, 2010, 16(6):763-764. [18] CLARK W, TANTI M, AZZAM I, et al.Unusual demyelinating disease in a patient with HIV infection[J]. J Neurovirol, 2024, 80(4):315. [19] GHEUENS S, PIERONE G, PEETERS P, et al.Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression[J]. J Neurol Neurosurps, 2009, 81(3): 247-254. [20] LARSON RA, DAI D, HOSACK VT, et al.Identification of a broad-spectrum arenavirus entry inhibitor[J]. J Virol, 2008, 82(21):10768-10775. [21] FRANCESCHI L.Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage[J]. Hepatology, 2000, 31(4):997-1004. [22] KARASAWA T, SAITO T, UENO Y, et al.Metabolome Analysis of Erythrocytes from Patients with Chronic Hepatitis C Reveals the Etiology of Ribavirin-Induced Hemolysis[J]. Int J Med Sci, 2013, 10(11):1575-1577. [23] 刘敏,曾琴,潘亮,等.聚乙二醇干扰素α-2b联合利巴韦林治疗HIV/HCV合并感染的回顾性研究[J/CD].新发传染病电子杂志,2021,6(1):31-34. [24] SALAM AP, DUVIGNAUD A, JASPARD M, et al.Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing[J]. PLoS Negl Trop Dis, 2022, 16(3): e0010289. [25] MCCORMICK JB, KING IJ, WEBB PA, et al.Lassa fever. Effective therapy with ribavirin[J]. N Engl J Med, 1986, 314(1):20-26 [26] EBERHARDT K A, MISCHLINGER J, JORDAN S, et al.Ribavirin for the Treatment of Lassa Fever: A Systematic Review and Meta-Analysis[J]. Int J Infect Dis, 2019, 87:15-20. [27] CHENG, HY, FRENCH, CE, SALAM, AP, et al.Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies1[J]. Emerg Infect Dis, 2022, 28(8): 1559-1568. |